Atara Biotherapeutics Presents Data Demonstrating Safety & Sustained Disability Improvement at 12 Months with ATA188 in Patients with Progressive Multiple Sclerosis in Late-Breaking e-Poster at th
Go back to Atara Biotherapeutics Presents Data Demonstrating Safety & Sustained Disability Improvement at 12 Months with ATA188 in Patients with Progressive Multiple Sclerosis in Late-Breaking e-Poster at th| (NASDAQ: ATRA) | Delayed: 9.76 -0.19 (1.91%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.95 | 52 Week High | $40.80 | |||
| Open | $10.06 | 52 Week Low | $12.45 | |||
| Day High | $10.06 | P/E | N/A | |||
| Day Low | $9.36 | EPS | $0.00 | |||
| Volume | 66,883 | |||||
